Market capitalization | $14.62m |
Enterprise Value | $16.18m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 107.90 |
P/S ratio (TTM) P/S ratio | 97.50 |
P/B ratio (TTM) P/B ratio | 0.17 |
Dividend yield | 0.00% |
Last dividend (FY24) | $8.96 |
As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.
1 Analyst has issued a forecast Trxade Group Inc:
1 Analyst has issued a forecast Trxade Group Inc:
Mar '25 |
+/-
%
|
||
Revenue | 0.15 0.15 |
98%
98%
|
|
Gross Profit | 0.01 0.01 |
99%
99%
|
|
EBITDA | -13 -13 |
29%
29%
|
EBIT (Operating Income) EBIT | -13 -13 |
29%
29%
|
Net Profit | -15 -15 |
477%
477%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Trxade Group, Inc. owns and operates a business-to-business Web-based marketplace focused on the pharmaceutical industry in the United States. It operates through Trxade, Inc.; Community Specialty Pharmacy, LLC; and Other segments. The company operates a Web based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories, and services. Its principal products and services include Trxade.com, a Web-based pharmaceutical marketplace; InventoryRx.com, a Web-based pharmaceutical exchange platform; Pharmabayonline that provides proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis to the United States-based independent pharmacies and pharmaceutical databases; and RxGuru, a desktop application, which provides product information. The company also operates a retail specialty pharmacy. In addition, it operates Delivmeds.com, a consumer-based app to provide delivery of pharmaceutical products; and Trxademso.com to assist independent retail pharmacies on pricing, distribution, and logistics. Trxade Group, Inc. is based in Land O'Lakes, Florida.
Head office | United States |
CEO | Surendra Ajjarapu |
Founded | 2005 |
Website | www.trxadehealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.